Kymera Therapeutics Inc (KYMR)
32.11
-0.05
(-0.16%)
USD |
NASDAQ |
May 31, 16:00
32.10
-0.02
(-0.05%)
After-Hours: 20:00
Kymera Therapeutics Total Assets (Quarterly): 868.25M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 868.25M |
| December 31, 2023 | 575.76M |
| September 30, 2023 | 552.38M |
| June 30, 2023 | 581.94M |
| March 31, 2023 | 613.90M |
| December 31, 2022 | 603.13M |
| September 30, 2022 | 638.47M |
| June 30, 2022 | 523.42M |
| March 31, 2022 | 563.06M |
| Date | Value |
|---|---|
| December 31, 2021 | 605.90M |
| September 30, 2021 | 642.45M |
| June 30, 2021 | 434.39M |
| March 31, 2021 | 464.55M |
| December 31, 2020 | 487.18M |
| September 30, 2020 | 507.36M |
| June 30, 2020 | 181.11M |
| December 31, 2019 | 116.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
116.70M
Minimum
Dec 2019
868.25M
Maximum
Mar 2024
527.06M
Average
563.06M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| SELLAS Life Sciences Group Inc | 24.43M |
| Iovance Biotherapeutics Inc | 869.83M |
| Immunic Inc | 104.16M |
| Protagonist Therapeutics Inc | 629.28M |
| Ovid Therapeutics Inc | 131.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 157.05M |
| Shareholders Equity (Quarterly) | 711.20M |
| Current Ratio | 9.571 |